HHS drops new guidance to bolster HIV med development

Modern Healthcare: The Food and Drug Administration finalized two guidances to support drugmakers developing new versions of HIV antiretroviral medications, HHS Secretary Alex Azar said on Tuesday.

Pledging to make eliminating the HIV epidemic a priority of his tenure, Azar said the FDA guidances focus on drugs to treat pediatric HIV infections as well as new long-acting forms of pre-exposure prophylaxis, or PrEP.

Read article